Switching Thermal Packaging Mid-Approval: What FDA Regulations Actually Require
A thermal packaging change during an approved or submitted commercialization state is a regulatory...
read Details
The global regulatory experts at Modality Solutions provide a detailed, tactical approach for meeting the new requirements for container closure integrity (CCI) of sterile pharmaceutical products detailed in the revised Annex 1 EU GMP.
Download the slide deck created by industry experts, Andrew Larrigan and Carson Dickey to understand how the changes to EU Annex 1 will impact your cold chain strategy for container closure integrity.
A thermal packaging change during an approved or submitted commercialization state is a regulatory...
read Details
A lower unit price on a thermal shipper can produce a higher total cost...
read Details
Thermal packaging is often treated as a single decision made once, at the start...
read Details